Neurotransmitter Signaling Pathways and Psychiatric Disorders

Neurotransmitter signaling pathways play a central role in regulating mood, cognition, and behavior. Dysregulation of dopamine, serotonin, glutamate, and GABA systems has been strongly linked to psychiatric conditions such as depression, schizophrenia, bipolar disorder, and anxiety disorders. Advances in receptor pharmacology, synaptic transmission studies, and intracellular signaling analysis are providing deeper insight into complex neurochemical imbalances. Modern imaging techniques and molecular profiling enable real-time assessment of neurotransmitter dynamics in both experimental and clinical settings. Emerging therapeutic strategies focus on receptor subtype selectivity, modulation of synaptic plasticity, and personalized pharmacological interventions. Integration of neurochemical research with genetics and environmental studies enhances understanding of multifactorial psychiatric disorders. Continued innovation in this field is critical for developing safer, more effective treatments and improving mental health outcomes worldwide.

    Related Conference of Neurotransmitter Signaling Pathways and Psychiatric Disorders

    March 09-10, 2026

    7th International Conference on Neurologists

    Singapore City, Singapore
    April 23-24, 2026

    8th World Depression Congress

    Paris, France
    May 14-15, 2026

    9th World Conference on Neuroscience

    Rome, Italy
    June 22-23, 2026

    7th World Congress on Sleep Disorders and Therapeutics

    Amsterdam, Netherlands
    June 22-23, 2026

    38th World Conference on Neurology

    Barcelona, Spain
    June 29-30, 2026

    37th Conference on Clinical Neuroscience and Neurogenetics

    Aix-en-Provence, France
    June 29-30, 2026

    39th European Neurology Congress

    London, UK
    July 20-21, 2026

    37th World Congress on Neurology and Neuroscience

    Amsterdam, Netherlands
    July 23-24, 2026

    16th Global Alzheimers Summit

    Paris, France
    July 23-24, 2026

    14th International Conference on Cannabis & Medicinal Research

    Amsterdam, Netherlands
    September 18-19, 2026

    21st Annual Congress on Neuroscience

    Dubai, UAE

    Neurotransmitter Signaling Pathways and Psychiatric Disorders Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in